Eupalinolide I is primarily studied for its anti-inflammatory and anti-cancer properties. It has shown potential in inhibiting the growth of certain tumor cells by inducing apoptosis and suppressing cell proliferation. Research indicates it may modulate signaling pathways involved in cancer development, such as NF-κB and MAPK pathways. Additionally, it exhibits immunomodulatory effects, making it a candidate for further investigation in therapeutic applications related to chronic inflammation and oncology. Its natural origin and bioactivity support its use in developing plant-based medicines and functional health products.